FDA recall, , Low risk
Huvepharma Sulmet Soluble Powder
Sulmet Soluble Powder has incorrect expiration dates printed on the primary packaging.
What happened
Huvepharma Inc., of Peachtree City, Georgia, voluntarily recalled Sulmet Soluble Powder (sodium sulfamethazine) because incorrect expiration dates were printed on the primary packaging, which are the pouches. The product is an antibacterial for animal use only, intended for beef cattle, dairy cattle, calves, swine, chickens, and turkeys. The recall began on October 21, 2026, and was added to the FDA's Enforcement Report on October 28, 2026.
The recalled product was distributed nationwide within the U.S. The company notified customers by letter. The recall was classified by the FDA on November 5, 2026.
What to do
The FDA notice gives no instructions for this recall. FDA's general advice for recalled products:
- Check the brand, package size and codes such as expiration dates against the notice.
- Return it to the store where you bought it, or dispose of it properly.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
Sulmet Soluble Powder (sodium sulfamethazine)
- NDC
- 23243-6500-1
- Lot code
- YSL057
- 1114165001
Recall details
- Posted by FDA
- Recall began
- Status
- Open
- Weekly archive
- Listed the week of Oct 26, 2026
- Sold in
Nationwide within the U.S.
- Recalled by
- Huvepharma IncPeachtree City, Georgia
- Hazard
- Labeling error
- Risk
Low risk
It is unlikely to cause health problems in animals it is used on.
FDA Class III recall · How risk is rated
- FDA event number
- 100189
- Recall number
- V-0013-2027
- Quantity recalled
- 108 cases (2160 pouches @ 1 lb. each), 2160 lbs.
- Recall type
- Voluntary: Firm initiated
- How the company first told customers
- Letter
All recalls from Huvepharma Inc
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
Huvepharma began the recall
FDA posted the recall to its Enforcement Report
Added to Recall Canary
FDA rated the recall Class III (low risk)
Summary updated



